Research Roundup

OFFICIAL PUBLICATION OF

by its subsidiary APPco

Megan Haggan 29/09/2020

Debbie Rigby takes a look at the latest in research news Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure The EMPEROR-Reduced Trial compared empagliflozin (10 mg once daily) or placebo (in addition to recommended therapy) in 3730 patients with heart failure and an ejection fraction of 40% or less. Results show a lower risk

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Recent Comments
Popular Posts

Wholesaling deal needs ‘radical restructure’ in 8CPA

Lazy choice of photo/illustration

Russell Smith

Hi, I’m your pharmacist!

A variation I use is 'I will be as fast as I safely can'

Troy Winslade

Monopolists a threat to small business

I'm sorry, but this appears to be a poor article. The "socialist" bank of the day was the Commonwealth Bank...but…

Tod O'Connor

Wholesaling deal needs ‘radical restructure’ in 8CPA

If the CSO money is redistributed directly to rural pharmacies then a wholesaler would probably surcharge deliveries to these rural…

Ernie Hanson

Research Roundup

Previous ‘Very, very lengthy delay’ torpedoes unfair dismissal case

Next COVID-19 and conduct: social media warning

Clinical tips: Timing!

Clinical tips: Movement disorders

Clinical tips: Worms, Worms, Worms

Intranasal Midazolam for at home use

MENU

Previous ‘Very, very lengthy delay’ torpedoes unfair dismissal case

Next COVID-19 and conduct: social media warning

Related Posts

MENU

Hi there! 👋 Looks like you’re not logged in.